Senior Manager, FP&A, Commercial and R&D
CSL Behring
This listing was originally posted on CSL Behring's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moThe Role
CSL Seqirus is one of the world's largest influenza vaccine providers, and its finances run in seasons: forecasts, inventory and workforce all move with the flu calendar. This role works alongside the Global Finance Business Partner for Seqirus Commercial and R&D. It provides the analysis, reporting and planning discipline that partnership depends on. You'll turn month-end numbers into a clear account of what drove the result, keep forecast and budget cycles running smoothly across markets, and help build the consistent processes and KPIs that let the business plan with confidence.
Hybrid based (3 days a week in office) in Maidenhead or Liverpool (UK) or Holly Springs, NC or Summit, NJ (US)
Why it matters
Seasonal influenza vaccines are planned, produced and distributed against a hard deadline every year. That makes accurate forecasting, inventory control and labour cost management more than routine finance. When the numbers are right and well explained, the business can direct resources to the markets and programmes that need them. This role helps make that happen. It explains variance rather than simply reporting it, tracks risks and opportunities as the season unfolds, and brings Commercial and R&D reporting onto a common footing. It also involves improving how the work gets done, through standardisation and automation, including AI use cases.
What You'll Be Responsible For
You'll support the Global Finance Business Partner across the Commercial FP&A cycle, from month end through forecast and budget, and contribute to bringing R&D reporting fully into the Seqirus FP&A team. You'll work with Commercial Finance colleagues, the wider Seqirus business and CSL Enterprise. You'll be expected to question the numbers as well as consolidate them.
Experience Required
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
Our Benefits
For more information on CSL benefits visit How CSL Supports Your Well-being | CSL.
You Belong at CSL
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future.
To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging
Equal Opportunity Employer
CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement.
Watch our ‘On the Front Line’ video to learn more about CSL Seqirus
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at CSL Behring?
Help others prepare — share your experience anonymously.
BIOTECHNOLOGY
Biologics
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo